James Anthony Datin

James Anthony Datin discloses dealings in FSD Pharma Inc. to SEDI. Over a trading history stretching from 11 June 2019 to 17 February 2021, the count stands at 4 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 22 February 2021 with a share grant (€65k) in FSD Pharma Inc. Between a trade and the moment it shows up on SEDI, the median delay is 6 days. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.